KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to 0.13%.

  • Pfizer's Return on Capital Employed rose 1300.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 1300.0%. This contributed to the annual value of 0.1% for FY2024, which is 300.0% up from last year.
  • According to the latest figures from Q3 2025, Pfizer's Return on Capital Employed is 0.13%, which was up 1300.0% from 0.11% recorded in Q2 2025.
  • Pfizer's Return on Capital Employed's 5-year high stood at 0.37% during Q4 2022, with a 5-year trough of 0.17% in Q4 2023.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.12% (2025), whereas its average is 0.1%.
  • As far as peak fluctuations go, Pfizer's Return on Capital Employed skyrocketed by 2100bps in 2021, and later tumbled by -4000bps in 2023.
  • Quarter analysis of 5 years shows Pfizer's Return on Capital Employed stood at 0.23% in 2021, then skyrocketed by 62bps to 0.37% in 2022, then crashed by -146bps to 0.17% in 2023, then surged by 100bps to 0.0% in 2024, then skyrocketed by 31096bps to 0.13% in 2025.
  • Its Return on Capital Employed was 0.13% in Q3 2025, compared to 0.11% in Q2 2025 and 0.11% in Q1 2025.